Privi Speciality Chemicals Limited · NSE:PRIVISCL
Privi Speciality Chemicals — Q1 FY27 Earnings Presentation
23 slides from Privi Speciality Chemicals's earnings presentation, Jul 30, 2026
Slide 1: Covering letter to stock exchanges
+ July 30,2026 The Manager (CRD) The Manager - Listing Department The BSE Limited National Stock Exchange of lndia Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no.Cft, G Block, Dalal Street, Fort, Bandra-Kurla Complex, Bandra (East) Mumbai- 400001 Mumbai- 400 05L Scrip Code: 530117 Symbol: PR
Slide 2: Investor Presentation Q1 FY26-27
Investor Presentation Q1 FY26-27 We d o d i ffe re nt t hi ng s, We d o t hi ng s d i ffe re nt l y Prosperity With Orderliness
Slide 3: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Privi Speciality Chemicals Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe fo
Slide 4: Index
Index 01 02 Highlight’s Q1 FY27 Results Strategic vision and performance overview Consolidated performance metrics 03 04 Company Overview Growth Strategy About Us Strategic priorities and outlook Prosperity With Orderliness
Slide 5: Highlights
Highlights ▪ Q1 FY27 marked a strong start to the year, reflecting the resilience of our business model and disciplined execution. ▪ We delivered Rs 681.42 Cr of total income representing 20.01% year-on-year growth, Rs 167.47 Cr of EBITDA with 18.73% year- on-year growth and Rs 84.21 Cr of Net Profi
Slide 6: Performance at a glance – Q1FY27
Performance at a glance – Q1FY27 Revenue EBITDA EBITDA Margin* PAT Rs. 681.42 Cr. Rs. 167.47 Cr. 24.58% Rs. 84.21 Cr. 20.01% YoY 18.73% YoY 27 bps 35.97% YoY ROCE ROE Net Debt to EBITDA Net Debt to Equity 21.70 % 22.72 % 1.29 0.57 299 bps YoY 112 bps YoY 35.41 % 40.86 % * The EBITDA margin is impact
Slide 7: Consolidated Profit & Loss Account
Consolidated Profit & Loss Account Particulars (Rs. Cr.) Q1FY27 Q1FY26 YoY FY26 FY25 YoY Revenue from operations 666.22 558.81 2,563.69 2,101.19 Other income 15.20 8.99 19.24 20.65 Total income 681.42 567.80 20.01% 2,582.92 2,121.84 21.73% Raw Material 371.60 275.25 1,317.10 1,131.49 Power and fuel
Slide 8: Q1 Performance across years
Q1 Performance across years Total Income EBITDA 167.5 681.4 141.1 567.8 466.7 97.1 414.8 Rs Cr Rs Cr 60.8 QE Jun-23 QE Jun-24 QE Jun-25 QE Jun-26 QE Jun-23 QE Jun-24 QE Jun-25 QE Jun-26 PAT % EBITDA % Net Profit 84.2 24.8% 24.6% 20.8% 61.9 14.6% Rs Cr 12.4% 10.9% 31.5 6.7% 4.6 1.1% QE Jun-23 QE Jun-
Slide 9: Annual Performance
Annual Performance Total Income (Rs. In Cr) EBITDA (Rs. In Cr) EBITDA Margin (%) PAT (Rs. In Cr) / Margin (%) 1.31% 5.37% 8.81% 12.68% +17% 2,582.92 2,121.84 25.76% 1,778.53 +48% 665.45 1,629.24 22.35% 327.54 474.16 19.95% +149% 187.00 354.82 12.73% 207.34 95.43 21.28 FY23 FY24 FY25 FY26 FY23 FY24 F
Slide 10: Company Overview
COMPANY OVERVIEW PRIVI SPECIALITY CHEMICALS LIMITED Prosperity With Orderliness
Slide 11: India's Leading Aroma Chemicals Manufacturer
Leading manufacturer, Supplier & Exporter of Aroma Chemicals India's Leading Aroma Chemicals Manufacturer A 30+ year track record of building global leadership in pine- based and speciality aroma chemicals — supplying the world's top fragrance and FMCG companies. 75+ 48,000 MTPA 2 R&D CENTRES 7 40+
Slide 12: Our Journey
Our Journey 2023 2025 2026 Way Forward Crossed turnover of Rs 1,500 Crores Turnover crossed Rs. 2,000 Crores. Turnover crossed Rs. 2,500 Crores. Working on 5K:1K plan Launched Galaxmusk, Camphor and Comissioned and commenced Prionyl. commercial production at PRIGIV 2021 2020 2019 2017 Promoter bough
Slide 13: Geographical Presence
Geographical Presence Manchester Rotterdam Milano Grasse New Jersey Mahad, Maharastra Jhagadia, Gujarat India Shanghai Mexico Singapore 2 Manufacturing 7 Distribution 3 Stocking Serving 40+ Sites Centres Points Countries Disclaimer: This map is a generalised illustration only for the ease of the rea
Slide 14: Competitive Advantages
Competitive Advantages Robust Manufacturing • Privi’s state-of-the-art manufacturing capacities are amongst the largest globally • Manufacturing infrastructure has the best-in-class regulatory compliance & certifications Backward Integration • Integrated inhouse developed CST processing for manufact
Slide 15: PRIGIV — Strategic JV with Givaudan
PRIGIV — Strategic JV with Givaudan PRIGIV Plant at Mahad, MH 51% 49% India's leading manufacturer of aroma Swiss multinational manufacturer of flavours, and fragrance chemicals fragrances and active cosmetic ingredients Globally trusted partner and a preferred World's largest company in the flavour
Slide 16: High R&D focus to develop new products and processes
High R&D focus to develop new products and processes R&D team strength 02 R&D Centers at 117 including scientist, microbiologist & chemistry DSIR recognition for both R&D centres extended till 2029 Mahad and Nerul professionals Synthetic Organic Research lab and Pilot plants are approved by the Depa
Slide 17: Operational Excellence: Driving Efficiency, Quality & Sustainability
Operational Excellence : Driving Efficiency, Quality & Sustainability Safety & People Sustainability R&D & Quality Process Efficiency Asset & Capacity • Regular safety audits • About 70% raw materials • 2 R&D centers (Mahad & Nerul) • Continuous process • Capacity debottlenecking and emergency drill
Slide 18: Growth Strategy
GROWTH STRATEGY PRIVI SPECIALITY CHEMICALS LIMITED Prosperity With Orderliness
Slide 19: Marching towards Vision – 5k | 1k Milestone
Marching towards Vision – 5k | 1k Milestone* New Projects and Products On track to achieve the vision of Rs 5,000 Cr revenue and Rs 1,000 Cr + EBITDA by FY29-30, representing more • Existing products expansion than 2x growth. • Maltol and Ethyl Maltol • Renewable Cyclopentanone • 10+ other High end
Slide 20: Proposed Scheme of Amalgamation
Proposed Scheme of Amalgamation Privi Fine Sciences Private Limited (PFSPL) + Privi Biotechnologies Private Limited (PBPL) + Privi Speciality Chemicals Limited (PSCL) Key Rationale Diverse Product Portfolio Green Science Advantage PFSPL includes Privial, Anethole, and Cyclamen Aldehyde used in fine
Slide 21: Key Growth Levers
Key Growth Levers Existing Product Expansion Expanding the reach of current products China +1 Strategy to increase sales Diversifying supply chains with a focus on China and additional 1 markets 6 New Product Innovation 2 Introducing new products, in synergy with existing raw material Incentive Grow
Slide 22: Key Business Highlights 5k:1k and beyond
Key Business Highlights 5k:1k and beyond Expansion Intellectual Capacity Information Biorefinery In-house talent Projects Property Augmentation Technology Speciality molecule Significant progress in Technology group Privi harnessing in- Flagship product Strengthening its expansion projects scaling b
Slide 23: Thank You
Thank You For further queries, Please contact: Company : Mr. Sanjeev Patil Executive Vice President - Strategy investors@privi.co.in www.privi.co.in Investor Relations Advisors : Adfactors PR Pvt. Ltd. Rushabh Shah: rushabh.shah@adfactorspr.com M: +91 8082180182 Pratik Shah: pratik.shah@adfactorspr.
Privi Speciality Chemicals — Q1 FY27 Earnings Presentation on 6ix